Noxon, a Munich-based medtech company, closed its seed funding round to advance its Muscle-Computer Interface. The wearable device combines continuous muscle diagnostics and neuromuscular electrical stimulation (NMES) for personalized rehabilitation and treatment of neuromuscular disorders.
Noxon closes seed funding round to advance muscle-computer interface technology
March 2, 2026